StockNews.AI

Select Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCAS

StockNews.AI · 3 hours

JPMWFCGSBCSSEM
High Materiality8/10

AI Summary

Select Medical closes its sale to a consortium led by Ortenzio, Jackson and WCAS for $16.50 per share, valuing the company at about $3.9 billion. The merger closes July 1, 2026, after stockholders approved on June 26, 2026, and the stock will be delisted on completion. Near-term investors should expect the stock to move toward the offer price with limited post-close upside.

Sentiment Rationale

The offer delivers an explicit premium to pre-announcement levels and VWAP, with near-term price convergence to $16.50; delisting implies no further upside beyond the deal value.

Trading Thesis

SEM will converge to $16.50 on close with minimal further upside after delisting.

Market-Moving

  • Merger closing date set for July 1, 2026; SEM to delist.
  • Offer price $16.50 per share; ~18% premium to pre-announcement price.
  • ~25% premium to 90-day VWAP through the announcement date.
  • Debt financing led by JPMorgan and Wells Fargo supports the close.

Key Facts

  • Select Medical acquired by a WCAS-led consortium; price $16.50 per share.
  • Deal values the company at about $3.9 billion; closing July 1, 2026.
  • Stock will cease trading on NYSE upon merger closing.
  • Officers Ortenzio and Jackson stay in leadership; stockholders approved June 26, 2026.

Companies Mentioned

  • Select Medical Holdings Corporation (SEM): Target; acquisition completed; delisting following closing.
  • Welsh, Carson, Anderson & Stowe (NA): Lead private-equity sponsor; strategic owner post-close.
  • JPMorgan Chase & Co. (JPM): Joint lead arranger for debt financing; potential funding certainty.
  • Wells Fargo & Co. (WFC): Joint lead bookrunner for debt financing; supports near-term close.
  • Goldman Sachs Group (GS): Exclusive financial advisor to Select Medical; involved in advisory process.
  • Barclays (BCS): Financial advisor to debt financing sources; part of financing syndicate.

M&A

Category: M&A. The article reports a completed take-private deal, reshaping SEM from a public healthcare services issuer to a privately held entity with a new controlling sponsor.

Related News